Results 61 to 70 of about 785,500 (213)

Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations

, 2023
Matthias Egger,1,2 Romuald Bellmann,3 Robert Krause,1,2 Johannes Boyer,1 Daniela Jakšić,4 Martin Hoenigl1,2,5,6 1Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria; 2Biotechmed-Graz, Graz ...
Bellmann R, Egger M, Krause R, Jakšić D, Boyer J, Hoenigl M   +5 more
core  

Mixed Invasive Fungal Pneumonia Caused by Aspergillus, Candida, Mucor in an Immunocompromised Host

Respirology Case Reports, Volume 14, Issue 11, November 2026.
We report a case of mixed invasive fungal pneumonia caused by Aspergillus, Candida and Mucor species in an immunocompromised host, highlighting the diagnostic and therapeutic implications of concurrent opportunistic fungal infections. ABSTRACT Invasive fungal pneumonia (IFP) is a life‐threatening complication in immunocompromised patients, particularly
Taeyun Kim, Eunjoo Jung, Yohan Jeon, Hyunji Choi, Ho‐Sup Lee, Tae‐Won Jang, Chul‐Ho Oak   +6 more
wiley   +1 more source

Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease

Brazilian Journal of Infectious Diseases
Aspergillosis is a disease caused by the filamentous fungus Aspergillus spp. with a spectrum of clinical presentation that includes invasive and noninvasive forms.
Jorge Alberto Cortés, Diego Andrés Rodríguez-Lugo, Martha Carolina Valderrama-Rios, Ricardo Rabagliati, Domenico Capone, Carlos Arturo Álvarez-Moreno, Fabio Varón-Vega, Laura Cristina Nocua-Báez, Cándida Diaz-Brochero, Leonardo Enciso Olivera, Sonia Isabel Cuervo-Maldonado, Luis Thompson, Dora E. Corzo-León, Luis E. Cuéllar, Erika Paola Vergara, Fernando Riera, Patricia Cornejo-Juárez, Rita Rojas, Beatriz L. Gómez, Adriana Marcela Celis-Ramírez, José Luis Sandoval-Gutiérrez, Mauricio Sarmiento, Diana Lorena Ochoa, Marcio Nucci   +23 more
doaj   +1 more source

Azole‐Resistant Aspergillosis: An Emerging Diagnostic and Therapeutic Challenge in Paediatrics

Mycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Introduction Invasive aspergillosis (IA) represents one of the most frequent invasive fungal infections in paediatric patients with risk factors. An increase in cases of azole‐resistant IA has been reported in adult patients. The aim of this study is to present a series of 11 cases of paediatric patients with this pathology.
Natalia Mendoza‐Palomar, Carlos Grasa Lozano, Begoña Carazo‐Gallego, Elena María Rincón‐López, Maria Pinyol‐Sarrias, Anna Creus‐Costa, Ana Méndez‐Echevarría, Alfredo Maldonado‐Barrueco, Yasmina Mozo, Diego Lozano‐Durán, Maria Luisa Navarro Gómez, Jesús Guinea, Maria Concepción Mediavilla Gradolph, Pere Soler‐Palacín, María Teresa Martín‐Gómez   +14 more
wiley   +1 more source

Treatment of Infections Due to Aspergillus terreus Species Complex

Journal of Fungi, 2018
The Aspergillus terreus species complex is found in a wide variety of habitats, and the spectrum of diseases caused covers allergic bronchopulmonary aspergillosis, Aspergillus bronchitis and/or tracheobronchitis, and invasive and disseminated ...
Cornelia Lass-Flörl
doaj   +1 more source

Primary Invasive Intestinal Aspergillosis in a Non-Severely Immunocompromised Patient [PDF]

Korean Journal of Critical Care Medicine, 2016
Invasive aspergillosis (IA) is most commonly seen in patients with risk factors, such as cytotoxic chemotherapy, prolonged neutropenia, corticosteroids, transplantation and acquired immune deficiency syndrome. IA commonly occurs in the respiratory tract.
Eunmi Gil, Tae Sun Ha, Gee Young Suh, Chi Ryang Chung, Chi-Min Park   +4 more
doaj   +1 more source

Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections

Mycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone, Pablo Bachiller‐Luque, Simone Giuliano, Sumita Pai, Berta Pernas, Carolina Garcia‐Vidal, Netta Tyler, Sara Ferin, Carlo Tascini, Ana Fernández Cruz   +9 more
wiley   +1 more source

Pediatric vs. Adult Invasive Aspergillosis in Cancer and Hematopoietic Transplant Patients: Insights from a Matched Cohort at a Tertiary Cancer Center

Journal of Fungi
Background: Invasive aspergillosis (IA) is a life-threatening infection in immunocompromised patients, including those with hematologic malignancies and hematopoietic stem cell transplants.
Saliba Wehbe, Ramia Zakhour, Ray Hachem, Ying Jiang, Hiba Dagher, Roseen Salman, Anne-Marie Chaftari, Issam I. Raad   +7 more
doaj   +1 more source

Investigation of Torque Teno Virus Loads as a Marker of Immunosuppression in Pediatric Chronic Renal Failure: A Pilot Study

Pediatric Transplantation, Volume 30, Issue 11, November 2026.
TTV is a promising marker to assess immune competence in a cohort of pediatric renal transplant recipients. Based on our data, immunosuppressive status and gender‐related factors affect TTV kinetics after transplantation and should be considered when interpreting TTV as a biomarker of immune function. ABSTRACT Background Torque Teno Virus (TTV), family
Ellen Kelly, Atif Awan, Dermot Wildes, Cillian F. De Gascun, Richard J. Drew, Alessandra Heggenstaller, Michael Riordan, Jaythoon Hassan   +7 more
wiley   +1 more source

Comparison of large epidemiological studies on invasive aspergillosis.

, 2016
Comparison of large epidemiological studies on invasive aspergillosis.
Solomon Chih-Cheng Chen (352134), Wan-Chun Huang (2270245), Kuo-Shao Sun (2270248), Yih-Yuan Chen (139708), Ching-Fang Tsai (715556)   +4 more
core   +1 more source